UOC
TNDM icon

UBS O'Connor’s Tandem Diabetes Care TNDM Stock Holding History

UBS O'Connor’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20,935
Closed -$941K – 720
2022
Q4 		$941K Sell
20,935
-5,695
-21% -$258K 0.02% 568
2022
Q3 		$1.27M Buy
26,630
+5,100
+24% +$280K 0.01% 717
2022
Q2 		$1.27M Buy
21,530
+12,145
+129% +$997K 0.01% 737
2022
Q1 		$1.09M Buy
+9,385
New +$1.1M 0.01% 682
2015
Q2 		– Sell
-9,460
Closed -$1.19M – 929
2015
Q1 		$1.19M Buy
+9,460
New +$1.23M 0.01% 488

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

UBS O'Connor's TNDM Position: Q1 2023 in Review

UBS O'Connor sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 20,935 shares — an estimated $941K sold.

UBS O'Connor first reported a position in TNDM in Q1 2015 and held it in 5 quarters. The position peaked at $1.27M in Q3 2022. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

  • UBS O'Connor reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
  • UBS O'Connor sold 20,935 Tandem Diabetes Care shares in Q1 2023, an estimated $941K.
  • UBS O'Connor first reported a position in Tandem Diabetes Care in Q1 2015 and held it in 5 quarters.
  • UBS O'Connor's Tandem Diabetes Care position peaked at $1.27M in Q3 2022.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.